Results 291 to 297 of about 354,756 (297)

Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity

Thrombosis and Haemostasis, 2010
J. Ryn, J. Stangier, S. Haertter, Karl‐Heinz Liesenfeld, W. Wienen, M. Feuring, A. Clemens   +6 more
semanticscholar   +1 more source

Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation: A Review

JAMA cardiology, 2017
J. Eikelboom, D. Quinlan, J. Hirsh, S. Connolly, J. Weitz   +4 more
semanticscholar   +1 more source

Anticoagulant and antiplatelet use in seniors with chronic subdural hematoma

Neurology, 2017
S. Nathan, Zahra Goodarzi, N. Jetté, C. Gallagher, J. Holroyd-Leduc   +4 more
semanticscholar   +1 more source

Rating the risks of anticoagulant rodenticides in the aquatic environment: a review

Environmental Chemistry Letters, 2018
J. Regnery, A. Friesen, Anke Geduhn, Bernd Göckener, M. Kotthoff, Pia Parrhysius, Eleonora Petersohn, G. Reifferscheid, E. Schmolz, R. Schulz, J. Schwarzbauer, M. Brinke   +11 more
semanticscholar   +1 more source

Perioperative management of anticoagulant and antiplatelet therapy

Heart, 2017
A. Tafur, J. Douketis
semanticscholar   +1 more source

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)

The Lancet, 1996
G. Palareti, N. Leali, S. Coccheri, M. Poggi, C. Manotti, A. D’Angelo, V. Pengo, N. Erba, M. Moia, N. Ciavarella, G. Devoto, M. Berrettini, S. Musolesi   +12 more
semanticscholar   +1 more source

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

The Lancet, 1993
T. Koster, J. Vandenbroucke, F. Rosendaal, H. D. Ronde, E. Briët, R. Bertina   +5 more
semanticscholar   +1 more source